RRs (95% CI) of leukoplakia developing into a SOM
| . | RR (95% CI) . | P . |
|---|---|---|
| LOH pattern | ||
| 3p Het vs. LOH | 4.23 (2.1–8.5) | <0.001 |
| 9p Het vs. LOH | 3.77 (1.7–8.4) | <0.001 |
| 4q Het vs. LOH | 2.61 (1.2–5.5) | 0.008 |
| 8p Het vs. LOH | 2.49 (1.2–5.1) | 0.01 |
| 11q Het vs. LOH | 2.85 (1.2–7.0) | 0.016 |
| 13q Het vs. LOH | 1.06 (0.37–3.0) | 0.92 |
| 17p Het vs. LOH | 1.18 (0.60–2.3) | 0.62 |
| 3p and/or 9p Het vs. LOH | ||
| 3p and/or 9p LOH (no other arms) | 23.5 (3.0–183) | <0.001 |
| 3p and/or 9p LOH (plus LOH at any other arm) | 25.4 (3.4–188) | <0.001 |
| All cases with 3p and/or 9p LOH | 26.3 (3.2–193) | <0.001 |
| Histological diagnosis | ||
| Hyperplasia or mild dysplasia vs. moderate or | 1.7 (0.87–3.4) | 0.11 |
| severe dysplasia |
| . | RR (95% CI) . | P . |
|---|---|---|
| LOH pattern | ||
| 3p Het vs. LOH | 4.23 (2.1–8.5) | <0.001 |
| 9p Het vs. LOH | 3.77 (1.7–8.4) | <0.001 |
| 4q Het vs. LOH | 2.61 (1.2–5.5) | 0.008 |
| 8p Het vs. LOH | 2.49 (1.2–5.1) | 0.01 |
| 11q Het vs. LOH | 2.85 (1.2–7.0) | 0.016 |
| 13q Het vs. LOH | 1.06 (0.37–3.0) | 0.92 |
| 17p Het vs. LOH | 1.18 (0.60–2.3) | 0.62 |
| 3p and/or 9p Het vs. LOH | ||
| 3p and/or 9p LOH (no other arms) | 23.5 (3.0–183) | <0.001 |
| 3p and/or 9p LOH (plus LOH at any other arm) | 25.4 (3.4–188) | <0.001 |
| All cases with 3p and/or 9p LOH | 26.3 (3.2–193) | <0.001 |
| Histological diagnosis | ||
| Hyperplasia or mild dysplasia vs. moderate or | 1.7 (0.87–3.4) | 0.11 |
| severe dysplasia |